Skip to main content
SpringerLink
Log in

Predicting type 1 diabetes

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Predicting type 1 diabetes mellitus (T1DM) is a prerequisite for disease prevention. Prediction is currently performed on three levels, which include the genetic susceptibility for disease, the identification of preclinical T1DM by way of circulating islet autoantibodies, and the use of metabolic tests to stage preclinical disease into late or early prediabetes. Combinations of genetic markers such as HLA genotype, INS genotype, and if and how much family history of T1DM is present can stratify disease risk more than 1000-fold, and can be used for selection of first-degree relatives of patients with T1DM for primary intervention trials. Measurement of autoantibodies in genetically at-risk subjects identifies future cases of T1DM. Further stratification of diabetes risk in autoantibody-positive subjects can be made on the basis of autoantibody characteristics that correspond to the magnitude of the autoantibody response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Redondo MJ, Eisenbarth GS: Genetic control of autoimmunity in type I diabetes and associated disorders. Diabetologia 2002, 45:605–622.

    Article  PubMed  CAS  Google Scholar 

  2. Hermann R, Bartsocas CS, Soltesz G, et al.: Genetic screening for individuals at high risk for type 1 diabetes in the general population using HLA class II alleles as disease markers. A comparison between three European populations with variable rates of disease incidence. Diabetes Metab Res Rev 2004, 20:322–329.

    Article  PubMed  CAS  Google Scholar 

  3. Buzzetti R, Galgani A, Petrone A, et al.: Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease (the DIABFIN study). Diabetes Metab Res Rev 2004, 20:137–143.

    Article  PubMed  CAS  Google Scholar 

  4. Van der Auwera BJ, Schuit FC, Weets I, et al.: Relative and absolute HLA-DQA1-DQB1 linked risk for developing type I diabetes before 40 years of age in the Belgian population: implications for future prevention studies. Hum Immunol 2002, 63:40–50.

    Article  PubMed  Google Scholar 

  5. Lambert AP, Gillespie KM, Thomson G, et al.: Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J Clin Endocrinol Metab 2004, 89:4037–4043. Stratifies the risk to develop T1DM in a large population-based U.K. family study solely based on genetic screening models, which could be considered for the design of future primary prevention trials in the general population.

    Article  PubMed  CAS  Google Scholar 

  6. Gillespie KM, Gale EA, Bingley PJ: High familial risk and genetic susceptibility in early onset childhood diabetes. Diabetes 2002, 51:210–214.

    Article  PubMed  CAS  Google Scholar 

  7. Walter M, Albert E, Conrad M, et al.: IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of type 1 diabetes and associated autoimmunity. Diabetologia 2003, 46:712–720.

    Article  PubMed  CAS  Google Scholar 

  8. Nejentsev S, Sjoroos M, Soukka T, et al.: Population-based genetic screening for the estimation of type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci. Diabet Med 1999, 16:985–992.

    Article  PubMed  CAS  Google Scholar 

  9. Rewers M, Bugawan TL, Norris JM, et al.: Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia 1996, 39:807–812.

    Article  PubMed  CAS  Google Scholar 

  10. Kupila A, Muona P, Simell T, et al.: Feasibility of genetic and immunological prediction of type I diabetes in a populationbased birth cohort. Diabetologia 2001, 44:290–297.

    Article  PubMed  CAS  Google Scholar 

  11. Yu J, Yu L, Bugawan TL, et al.: Transient anti-islet autoantibodies: infrequent occurrence and lack of association with "genetic" risk factors. J Clin Endocrinol Metab 2000, 85:2421–2428.

    Article  PubMed  CAS  Google Scholar 

  12. Laine AP, Hermann R, Knip M, et al.: The human leukocyte antigen genotype has a modest effect on the insulin gene polymorphism-associated susceptibility to type 1 diabetes in the Finnish population. Tissue Antigens 2004, 63:72–74. Investigates the effect of the INS gene polymorphism on T1DM risk in more than 3500 children from Finland. The findings conclusively show that the INS gene polymorphisms modify T1DM risk in all subjects, irrespective of their HLA genotype. This implies that combining the INS gene and HLA will improve our ability to predict T1DM (see also Walter et al. [7]) and that there is direct interaction between the HLA and INS genes in conferring risk (see also Motzo et al. [13]).

    Article  PubMed  CAS  Google Scholar 

  13. Motzo C, Contu D, Cordell HJ, et al.: Heterogeneity in the magnitude of the insulin gene effect on HLA risk in type 1 diabetes. Diabetes 2004, 53:3286–3291.

    Article  PubMed  CAS  Google Scholar 

  14. Ziegler AG, Schmid S, Huber D, et al.: Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 2003, 290:1721–1728.

    Article  PubMed  CAS  Google Scholar 

  15. Norris JM, Barriga K, Klingensmith G, et al.: Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 2003, 290:1713–1720.

    Article  PubMed  CAS  Google Scholar 

  16. Yu L, Cuthbertson DD, Eisenbarth GS, Krischer JP: Diabetes Prevention Trial 1: prevalence of GAD and ICA512 (IA-2) autoantibodies by relationship to proband. Ann N Y Acad Sci 2002, 958:254–258.

    Article  PubMed  CAS  Google Scholar 

  17. Bonifacio E, Hummel M, Walter M, et al.: IDDM1 and multiple family history of type 1 diabetes combine to identify neonates at high risk for type 1 diabetes. Diabetes Care 2004, 27:2695–2700.

    Article  PubMed  Google Scholar 

  18. Atkinson MA, Eisenbarth GS: Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001, 358:221–229.

    Article  PubMed  CAS  Google Scholar 

  19. Bingley PJ, Bonifacio E, Ziegler AG, et al.: Proposed guidelines on screening for risk of type 1 diabetes. Diabetes Care 2001, 24:398.

    Article  PubMed  CAS  Google Scholar 

  20. Bingley PJ, Bonifacio E, Mueller PW: Diabetes antibody standardization program: first assay proficiency evaluation. Diabetes 2003, 52:1128–1136.

    Article  PubMed  CAS  Google Scholar 

  21. Mire-Sluis AR, Gaines Das R, Lernmark A: The World Health Organization International Collaborative Study for islet cell antibodies. Diabetologia 2000, 43:1282–1292.

    Article  PubMed  CAS  Google Scholar 

  22. Kulmala P, Savola K, Petersen JS, et al.: Prediction of insulindependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. J Clin Invest 1998, 101:327–336.

    Article  PubMed  CAS  Google Scholar 

  23. Decochez K, De Leeuw IH, Keymeulen B, et al.: IA-2 autoantibodies predict impending type I diabetes in siblings of patients. Diabetologia 2002, 45:1658–1666.

    Article  PubMed  CAS  Google Scholar 

  24. Bingley PJ, Williams AJ, Gale EA: Optimized autoantibodybased risk assessment in family members. Implications for future intervention trials. Diabetes Care 1999, 22:1796–1801.

    Article  PubMed  CAS  Google Scholar 

  25. Krischer JP, Cuthbertson DD, Yu L, et al.: Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. J Clin Endocrinol Metab 2003, 88:103–108. Measured four islet autoantibodies in more than 17,000 first- and second-degree relatives of patients with T1DM, representing the largest antibody screening program in any autoimmune disease so far reported. It compares the efficacy of different screening approaches for identification of multiple autoantibody-positive subjects at increased diabetes risk.

    Article  PubMed  CAS  Google Scholar 

  26. Achenbach P, Warncke K, Reiter J, et al.: Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes 2004, 53:384–392. Identified characteristics of the humoral autoimmune response in pre-T1DM that can be used for a more accurate prediction of diabetes risk in islet autoantibody-positive relatives. The findings are highly relevant for selection of participants for future immune intervention trials.

    Article  PubMed  CAS  Google Scholar 

  27. Achenbach P, Koczwara K, Knopff A, et al.: Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest 2004, 114:589–597. Identified insulin-binding characteristics of IAAs that can serve as early markers of T1DM-relevant insulin autoimmunity and effectively predict progression to T1DM in young children.

    Article  PubMed  CAS  Google Scholar 

  28. Fourlanos S, Narendran P, Byrnes GB, et al.: Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 2004, 47:1661–1667.

    Article  PubMed  CAS  Google Scholar 

  29. Chase HP, Cooper S, Osberg I, et al.: Elevated C-reactive protein levels in the development of type 1 diabetes. Diabetes 2004, 53:2569–2573.

    Article  PubMed  CAS  Google Scholar 

  30. Yu L, Robles DT, Abiru N, et al.: Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci U S A 2000, 97:1701–1706.

    Article  PubMed  CAS  Google Scholar 

  31. Ziegler AG, Hummel M, Schenker M, Bonifacio E: Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 1999, 48:460–468.

    Article  PubMed  CAS  Google Scholar 

  32. Kimpimaki T, Kulmala P, Savola K, et al.: Natural history of betacell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 2002, 87:4572–4579.

    Article  PubMed  CAS  Google Scholar 

  33. Hummel M, Bonifacio E, Schmid S, et al.: Early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents. Ann Intern Med 2004, 140:882–886. Provides the most recent update on the longest-running prospective study in the field investigating the natural history of T1DM in more than 1600 offspring of patients with T1DM from Germany who have been followed from birth for up to 15 years. The study has identified characteristics of early childhood islet autoimmunity that have significant impact on the progression to T1DM.

    PubMed  Google Scholar 

  34. Barker JM, Barriga KJ, Yu L, et al.: Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 2004, 89:3896–3902. Gives the latest update on a large prospective study from the United States investigating the natural history of T1DM in at-risk children from affected families and the general population who have been followed from birth for up to 10 years.

    Article  PubMed  CAS  Google Scholar 

  35. Colman PG, Steele C, Couper JJ, et al.: Islet autoimmunity in infants with a type I diabetic relative is common but is frequently restricted to one autoantibody. Diabetologia 2000, 43:203–209.

    Article  PubMed  CAS  Google Scholar 

  36. Naserke HE, Bonifacio E, Ziegler AG: Prevalence, characteristics and diabetes risk associated with transient maternally acquired islet antibodies and persistent islet antibodies in offspring of parents with type 1 diabetes. J Clin Endocrinol Metab 2001, 86:4826–4833.

    Article  PubMed  CAS  Google Scholar 

  37. Hamalainen AM, Ronkainen MS, Akerblom HK, Knip M: Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes. The Finnish TRIGR Study Group. Trial to Reduce IDDM in the Genetically at Risk. J Clin Endocrinol Metab 2000, 85:4249–4253.

    Article  PubMed  CAS  Google Scholar 

  38. Ziegler AG, Ziegler R, Vardi P, et al.: Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type I diabetes. Diabetes 1989, 38:1320–1325.

    Article  PubMed  CAS  Google Scholar 

  39. Bingley PJ, Christie MR, Bonifacio E, et al.: Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994, 43:1304–1310.

    Article  PubMed  CAS  Google Scholar 

  40. LaGasse JM, Brantley MS, Leech NJ, et al.: Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study. Diabetes Care 2002, 25:505–511.

    Article  PubMed  Google Scholar 

  41. Strebelow M, Schlosser M, Ziegler B, et al.: Karlsburg type I diabetes risk study of a general population: frequencies and interactions of the four major type I diabetes-associated autoantibodies studied in 9419 schoolchildren. Diabetologia 1999, 42:661–670.

    Article  PubMed  CAS  Google Scholar 

  42. Bonifacio E, Bingley PJ, Shattock M, et al.: Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990, 335:147–149.

    Article  PubMed  CAS  Google Scholar 

  43. Vardi P, Ziegler AG, Mathews JH, et al.: Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age. Diabetes Care 1988, 11:736–739.

    PubMed  CAS  Google Scholar 

  44. Harrison LC, Honeyman MC, DeAizpurua HJ, et al.: Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 1993, 341:1365–1369.

    Article  PubMed  CAS  Google Scholar 

  45. Diabetes Prevention Trial—Type 1 Diabetes Study Group:Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002, 346:1685–1691.

    Article  Google Scholar 

  46. Chase HP, Cuthbertson DD, Dolan LM, et al.: First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes. J Pediatr 2001, 138:244–249.

    Article  PubMed  CAS  Google Scholar 

  47. Keskinen P, Korhonen S, Kupila A, et al.: First-phase insulin response in young healthy children at genetic and immunological risk for type I diabetes. Diabetologia 2002, 45:1639–1648.

    Article  PubMed  CAS  Google Scholar 

  48. Kulmala P, Savola K, Reijonen H, et al.: Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children. Childhood Diabetes in Finland Study Group. Diabetes 2000, 49:48–58.

    Article  PubMed  CAS  Google Scholar 

  49. Pugliese A, Gianani R, Moromisato R, et al.: HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes 1995, 44:608–613.

    Article  PubMed  CAS  Google Scholar 

  50. Schlosser M, Wassmuth R, Strebelow M, et al.: Multiple and high-titer single autoantibodies in schoolchildren reflecting the genetic predisposition for type 1 diabetes. Ann N Y Acad Sci 2003, 1005:98–108.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diabetes Research Institute, Koelner Platz 1, 80804, Munich, Germany

    Peter Achenbach MD, Ezio Bonifacio PhD & Anette-G. Ziegler MD

Authors
  1. Peter Achenbach MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ezio Bonifacio PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anette-G. Ziegler MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Achenbach, P., Bonifacio, E. & Ziegler, AG. Predicting type 1 diabetes. Curr Diab Rep 5, 98–103 (2005). https://doi.org/10.1007/s11892-005-0035-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-005-0035-y

Keywords

Search

Navigation